학술논문

The GIRAFE phase II trial on MVCT-based “volumes of the day” and “dose of the day” addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer
Document Type
Article
Source
In: Clinical and Translational Radiation Oncology. (Clinical and Translational Radiation Oncology, May 2019, 16:34-39)
Subject
Language
English
ISSN
24056308